JP2023525756A5 - - Google Patents

Info

Publication number
JP2023525756A5
JP2023525756A5 JP2022567881A JP2022567881A JP2023525756A5 JP 2023525756 A5 JP2023525756 A5 JP 2023525756A5 JP 2022567881 A JP2022567881 A JP 2022567881A JP 2022567881 A JP2022567881 A JP 2022567881A JP 2023525756 A5 JP2023525756 A5 JP 2023525756A5
Authority
JP
Japan
Prior art keywords
disease
independently
alkyl
case
syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022567881A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023525756A (ja
JP7757312B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/031325 external-priority patent/WO2021226477A1/en
Publication of JP2023525756A publication Critical patent/JP2023525756A/ja
Publication of JP2023525756A5 publication Critical patent/JP2023525756A5/ja
Priority to JP2025169839A priority Critical patent/JP2026027231A/ja
Application granted granted Critical
Publication of JP7757312B2 publication Critical patent/JP7757312B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022567881A 2020-05-08 2021-05-07 Akt3モジュレーター Active JP7757312B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025169839A JP2026027231A (ja) 2020-05-08 2025-10-08 Akt3モジュレーター

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063021987P 2020-05-08 2020-05-08
US63/021,987 2020-05-08
US202063121001P 2020-12-03 2020-12-03
US63/121,001 2020-12-03
PCT/US2021/031325 WO2021226477A1 (en) 2020-05-08 2021-05-07 Akt3 modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025169839A Division JP2026027231A (ja) 2020-05-08 2025-10-08 Akt3モジュレーター

Publications (3)

Publication Number Publication Date
JP2023525756A JP2023525756A (ja) 2023-06-19
JP2023525756A5 true JP2023525756A5 (cg-RX-API-DMAC10.html) 2024-05-16
JP7757312B2 JP7757312B2 (ja) 2025-10-21

Family

ID=78468493

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022567881A Active JP7757312B2 (ja) 2020-05-08 2021-05-07 Akt3モジュレーター
JP2025169839A Pending JP2026027231A (ja) 2020-05-08 2025-10-08 Akt3モジュレーター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025169839A Pending JP2026027231A (ja) 2020-05-08 2025-10-08 Akt3モジュレーター

Country Status (12)

Country Link
US (1) US20240228457A1 (cg-RX-API-DMAC10.html)
EP (1) EP4146185A4 (cg-RX-API-DMAC10.html)
JP (2) JP7757312B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230022458A (cg-RX-API-DMAC10.html)
CN (1) CN115867266A (cg-RX-API-DMAC10.html)
AU (1) AU2021267042A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022022549A2 (cg-RX-API-DMAC10.html)
CA (1) CA3182273A1 (cg-RX-API-DMAC10.html)
IL (2) IL297597A (cg-RX-API-DMAC10.html)
MX (1) MX2022014018A (cg-RX-API-DMAC10.html)
PH (1) PH12022553034A1 (cg-RX-API-DMAC10.html)
WO (1) WO2021226477A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021212111A1 (en) * 2020-04-17 2021-10-21 Augusta University Research Institute, Inc. Compositions and methods for treating leukemia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1158266C (zh) * 1998-10-01 2004-07-21 阿斯特拉曾尼卡有限公司 化合物
TW200536536A (en) 2004-02-25 2005-11-16 Schering Corp Pyrazolotriazines as kinase inhibitors
US7939546B2 (en) * 2007-10-12 2011-05-10 Supergen, Inc. Quinoline derivatives for modulating DNA methylation
KR101106050B1 (ko) * 2009-03-25 2012-01-18 한국과학기술연구원 아미노퀴놀린 화합물, 이의 제조 방법 및 이를 함유하는 의약 조성물
RU2016122731A (ru) * 2013-11-25 2018-01-09 Новоген Лтд Функционализированные и замещенные индолы в качестве противораковых агентов
CN106543143B (zh) * 2015-09-22 2019-03-22 合肥中科普瑞昇生物医药科技有限公司 一类新型的flt3激酶抑制剂及其用途
US10292978B2 (en) * 2016-01-15 2019-05-21 Augusta University Research Institute, Inc. Specific Akt3 inhibitor and uses thereof
US10342868B2 (en) * 2016-01-15 2019-07-09 Augusta University Research Institute, Inc. Methods and compositions for inhibiting Akt3
US11291719B2 (en) 2016-01-15 2022-04-05 Augusta University Research Institute, Inc. Methods and compositions for modulating Akt3
CN106496107A (zh) * 2016-08-31 2017-03-15 浙江永宁药业股份有限公司 Vegfr‑2抑制剂及其制备方法
WO2021212111A1 (en) 2020-04-17 2021-10-21 Augusta University Research Institute, Inc. Compositions and methods for treating leukemia
US20230295114A1 (en) 2020-05-08 2023-09-21 Georgiamune Llc Akt3 modulators

Similar Documents

Publication Publication Date Title
JP2023525757A5 (cg-RX-API-DMAC10.html)
AU2023202592B2 (en) Modulators of the integrated stress pathway
JP2023524600A5 (cg-RX-API-DMAC10.html)
AU2018358157B2 (en) Modulators of the integrated stress pathway
JP2023524596A5 (cg-RX-API-DMAC10.html)
JP7307057B2 (ja) 統合的ストレス経路の調節剤
CA2972014A1 (en) Fused pyrimidine compounds for the treatment of hiv
AU2018360850A1 (en) Modulators of the integrated stress pathway
CA2643177A1 (en) Multi-cyclic compounds for treating cancer
JP2024541995A5 (cg-RX-API-DMAC10.html)
HUP0301213A2 (hu) Ciklin dependens kinázok amino-tiazol inhibitorai, ezeket tartalmazó gyógyszerkészítmények, előállításuk és alkalmazásuk
CZ297907B6 (cs) Aminothiazolové deriváty a farmaceutické kompozice s jejich obsahem
CA3008747A1 (en) Novel compounds
EP3704089A1 (en) Modulators of the integrated stress pathway
MX2009001036A (es) Pirazolopirimidinas, proceso para su preparacion y su uso como medicina.
JP2010528021A5 (cg-RX-API-DMAC10.html)
JP2024540107A5 (cg-RX-API-DMAC10.html)
JP2017532360A5 (cg-RX-API-DMAC10.html)
JP2021535112A5 (cg-RX-API-DMAC10.html)
KR20090055562A (ko) 오로라 a 선택적 억제 작용을 갖는 신규한 아미노피리딘 유도체
JP2022536901A5 (cg-RX-API-DMAC10.html)
TWI544920B (zh) N-羥基-4-{2-[3-(n,n-二甲基胺基甲基)苯並呋喃-2-基羰基胺基]乙氧基}苯甲醯胺之新穎投藥法
JP2009504771A5 (cg-RX-API-DMAC10.html)
JP2024541994A5 (cg-RX-API-DMAC10.html)
CN106414448B (zh) 可用作s100-抑制剂的新型化合物